Therapeutic Efficacy of Maxiletine for Long QT Syndrome Type 2: Evidennce From Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes, Transgenic Rabbits, and Patients. ―高リスクのQT延長症候群2型患者にメキシレチンを投与すべきであるー

Journal Club

Therapeutic Efficacy of Maxiletine for Long QT Syndrome Type 2: Evidennce From Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes, Transgenic Rabbits, and Patients. ―高リスクのQT延長症候群2型患者にメキシレチンを投与すべきであるー

2024/07/15

Therapeutic Efficacy of Maxiletine for Long QT Syndrome Type 2: Evidennce From Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes, Transgenic Rabbits, and Patients.

―高リスクのQT延長症候群2型患者にメキシレチンを投与すべきであるー

こちら

PageTop